China Meheco Group Co Ltd
SSE:600056
Intrinsic Value
China Meheco Group Co., Ltd. engages in the wholesale of medicine, drugs, and Chinese herbal medicine. [ Read More ]
The intrinsic value of one China Meheco Group Co Ltd stock under the Base Case scenario is 14.32 CNY. Compared to the current market price of 11.18 CNY, China Meheco Group Co Ltd is Undervalued by 22%.
Valuation Backtest
China Meheco Group Co Ltd
Run backtest to discover the historical profit from buying and selling China Meheco Group Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
China Meheco Group Co Ltd
| Current Assets | 29.1B |
| Cash & Short-Term Investments | 3B |
| Receivables | 17.7B |
| Other Current Assets | 8.4B |
| Non-Current Assets | 9.1B |
| Long-Term Investments | 2.8B |
| PP&E | 2.9B |
| Intangibles | 2.1B |
| Other Non-Current Assets | 1.3B |
| Current Liabilities | 19B |
| Accounts Payable | 9.5B |
| Accrued Liabilities | 279.8m |
| Short-Term Debt | 3.2B |
| Other Current Liabilities | 6B |
| Non-Current Liabilities | 8B |
| Long-Term Debt | 3.3B |
| Other Non-Current Liabilities | 4.6B |
Earnings Waterfall
China Meheco Group Co Ltd
|
Revenue
|
40.5B
CNY
|
|
Cost of Revenue
|
-36B
CNY
|
|
Gross Profit
|
4.5B
CNY
|
|
Operating Expenses
|
-3.4B
CNY
|
|
Operating Income
|
1.1B
CNY
|
|
Other Expenses
|
-563.2m
CNY
|
|
Net Income
|
563.1m
CNY
|
Free Cash Flow Analysis
China Meheco Group Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
China Meheco Group Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
China Meheco Group Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China Meheco Group Co Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
China Meheco Group Co Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
China Meheco Group Co Ltd
According to Wall Street analysts, the average 1-year price target for China Meheco Group Co Ltd is 30.47 CNY .
Shareholder Return
Price
China Meheco Group Co Ltd
| Average Annual Return | 21.62% |
| Standard Deviation of Annual Returns | 56.04% |
| Max Drawdown | -65% |
| Market Capitalization | 16.7B CNY |
| Shares Outstanding | 1 495 880 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
China Meheco Group Co., Ltd. engages in the wholesale of medicine, drugs, and Chinese herbal medicine. The company is headquartered in Beijing, Beijing and currently employs 8,715 full-time employees. Industrial Pharmaceutical segment mainly involves in the manufacture and distribution of chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, herbal decoction pieces and other pharmaceutical products. Commercial Pharmaceutical segment is mainly engaged in the wholesale and distribution of pharmaceuticals and medical devices. Trading segment is mainly engaged in the international exporting business and medical resourcing introduction.
Contact
IPO
Employees
Officers
The intrinsic value of one China Meheco Group Co Ltd stock under the Base Case scenario is 14.32 CNY.
Compared to the current market price of 11.18 CNY, China Meheco Group Co Ltd is Undervalued by 22%.
You don't have any saved screeners yet
